Luke McLaughlin: Haemophilia Care as a Matter of Global Health Equity
Luke McLaughlin, Founder of The Haemophilia Rights Project, shared World Federation of Hemophilia‘s post on LinkedIn, adding:
“The significance of this milestone should not be understated.
The advancement of medical treatments in Haemophilia can only be seen as revolutionary if they are equally distributed around the globe.
No human should be too expensive or inconvenient to treat. Cost should never be an excuse to disregard human rights.
I commend Armenia, World Federation of Hemophilia and the unilateral coalition of supporting states for highlighting treatment equity in Haemophilia at the highest international level.
Treatment should be a right for all people with Haemophilia and bleeding disorders.”
World Federation of Hemophilia (WFH) shared a post on LinkedIn:
“Today marks a historic milestone for the global Bleeding Disorders community.
The 79th World Health Assembly has adopted the resolution on ‘Global action to advance health equity for people with hemophilia and other bleeding disorders.’
This landmark adoption recognizes the urgent need to improve diagnosis, access to treatment, comprehensive care, and health equity for people living with bleeding disorders around the world.
It signals commitment by the WHO and Member States to advance these priorities.
Watch the address of Cesar Garrido, the WFH President, at the WHA79.
The World Federation of Hemophilia extends its sincere gratitude to Armenia for its leadership, as well as to all co-sponsoring Member States – in addition to all the partners, advocates, healthcare professionals, national member organizations, and community members whose collaboration helped make this possible, including over 100 organizations that joined the WFH’s Global Call for Health Equity for Bleeding Disorders.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026